Translocation t(2;8)(p12;q24) in two patients with B cell chronic lymphocytic leukemia

Acta Haematologica

Volumn 120, Issue 4, 2009, Pages 232-236

  Dai, Hai Ping ^a   Xue, Yong Quan ^a   Zhang, Jun ^a   Wu, Ya Fang ^a   Pan, Jin Lan ^a   Wang, Yong ^a   Shen, Juan ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Burkitt lymphoma; Chromosome translocation; Chronic lymphocytic leukemia; Fluorescence in situ hybridization

Indexed keywords

CD38 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; MITOXANTRONE; PREDNISONE; PROTEIN KINASE ZAP 70; PROTEIN P53; VINCRISTINE;

AGED; ALLELE; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CANCER PATIENT; CASE REPORT; CELL STRUCTURE; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOSS; GENE TRANSLOCATION; HEART FAILURE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL COUNT; ONCOGENE MYC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIDE EFFECT;

AGED; ANTIGENS, CD38; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 8; FATAL OUTCOME; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MEMBRANE GLYCOPROTEINS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 60749110689     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000203402     Document Type: Article

References (31)

1. Croce CM, Nowell PC: Molecular basis of human B cell neoplasia. Blood 1985;65:1-7.
2. Dalla-Favera R, Martinotti S, Gallo RC, Erikson J, Croce CM: Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 1983;4587:963-967.
3. Mitelman F, Johansson B, Mertens F (eds): Mitelman database of chromosome aberrations in cancer. 2008. http://cgap.nci.nih. gov/Chromosomes/ RecurrentAberrations.
4. Cory S: Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res 1986;47:189-234.
5. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Guneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromo somal abnormalities. N Engl J Med 1990;323:720-724.
6. Asou N, Osato M, Horikawa K, Nishikawa K, Sakitani O, Li L, Yamasaki H, Nishimura S, Okubo T, Suzushima H, Takatsuki K: Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. Leukemia 1997;11:1986-1988.
7. Fleischman EW, Prigogina EL: Karyotype peculiarities of malignant lymphomas. Hum Genet 1977;35:269-279.
8. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD: There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 1985;66:1414-1422.
9. Mark HF, Sotomayor E, Mega A: Occurrence of both t(1;19) and t(8;14) in a patient with chronic lymphocytic leukemia. Exp Mol Pathol 1999;66:238-242.
10. Palka G, Fioritoni G, Lombardo M, Donti E, Calabrese G, Stuppia L, Di Marco G, Guanciali Franchi P, Parruti G, Geraci L: Chromosome abnormalities in PHA-stimulated and non stimulated bone marrow cultures from patients with non Hodgkin lymphoma. Haematologica 1988;73: 489-494.
11. Reddy KS: Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol 2006;132:705-722.
12. Reddy K, Satyadev R, Bouman D, Hibbard MK, Lu G, Paolo R: Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature. Cancer Genet Cytogenet 2006;166:12-21.
13. Juliusson G, Friberg K, Gahrton G: Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. A longitudinal cytogenetic study of 41 patients. Cancer 1988;62:500-506.
14. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94:1848-1854.
15. Hsiao HH, Hung YH, Hsiao HP, Tseng SB, Tsai HJ, Liu YC, Liu TC, Chao MC, Chang Y, Lin SF: Case of chronic lymphocytic leukemia with unusual chromosome aberrations. Int J Hematol 2004;80:351-355.
16. Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ: Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 2003;127:305-309.
17. Solé F, Woessner S, Pérez-Losada A, Florensa L, Montero S, Asensio A, Besses C, Sans-Sabrafen J: Cytogenetic studies in seventy-six cases of B-chronic lymphoproliferative disorders. Cancer Genet Cytogenet 1997;93:160-166.
18. Struski S, Leymarie V, Helias C, Falkenrodt A, Fohrer C, Audhuy B, Lioure B, Moskovtchenko P, Mazurier I, Galoisy AC, Gervais C, Mauvieux L, Herbrecht R, Bergerat JP, Lessard M: A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies (in French). Pathol Biol (Paris) 2007;55:59-72.
19. Xue Y, Yu F, Zhou Z, He Z, Guo Y, Wang M, Lin B: Complex karyotypic abnormalities including t(8;22) in a patient with chronic lymphocytic leukemia. Cancer Genet Cytogenet 1993;65:157-160.
20. Mohamed AN, Compean R, Dan ME, Smith MR, Al-Katib A: Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996;86:143-146.
21. Litz CE, Arthur DC, Gajl-Peczalska KJ, Rausch D, Copenhaver C, Coad JE, Brunning RD: Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological and molecular study. Leukemia 1991;5:972-978.
22. Shaffer LG, Tommerup N: ISCN 2005: An International System for Human Cytogenetics Nomenclature. Basel, Karger, 2005.
23. Li T, Xue Y, Wu Y, Pan J: Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 2004;125:337-342.
24. Catovsky D, Montserrat E, Müller-Hermelink HK, Harris NL: B-cell prolymphocytic leukaemia;in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): Tumours of Haemopoetic and Lymphoid Tissues: World Health Organization Classification of Tumors. Lyon, IARC Press, 2001, pp 131-132.
25. DiGiuseppe JA, Borowitz MJ: Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998;25:6-10.
26. Robert KH: PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia. Clin Exp Immunol 1979;37:517-522.
27. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990;55:133-270.
28. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, Stewart M, Donehower LA, Onions DE, Neil JC, Cameron ER: Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 1995;10:1717-1723.
29. Wong KF, Kwong YL, Hui PK: Hairy cell leukemia variant with t(2;8)(p12;q24) abnormality. Cancer Genet Cytogenet 1997;98:102-105.
30. Potti A, Panwalkar A, Ingebretson MC, Tharapel SA, Goodell M, Dayton MV, Mehdi SA: An indolent B-cell lymphoma with t(2; 8)(p12;q24) abnormality and absence of CMYC amplification and TP53 deletion: a new variant? Cancer Genet Cytogenet 2003;144:76-79.
31. Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J: Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005;19:750-758.